University of California, San Francisco, CA.
University of California, San Francisco, CA.
Am J Kidney Dis. 2014 Apr;63(4):590-7. doi: 10.1053/j.ajkd.2013.10.055. Epub 2013 Dec 2.
Identifying potentially modifiable risk factors is critically important for reducing the burden of chronic kidney disease. We sought to examine the association of body mass index (BMI) with kidney function decline in a cohort of young adults with preserved glomerular filtration at baseline.
Longitudinal cohort.
SETTING & PARTICIPANTS: 2,839 black and white young adults with cystatin C-based estimated glomerular filtration rate (eGFRcys)>90mL/min/1.73m(2) taking part in the year-10 examination (in 1995-1996) of the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
BMI, categorized as 18.5-24.9 (reference), 25.0-29.9, 30.0-39.9, and ≥40.0kg/m(2).
Trajectory of kidney function decline, rapid decline (>3% per year), and incident eGFRcys <60mL/min/1.73m(2) over 10 years of follow-up.
GFRcys estimated from the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation for calibrated cystatin C at CARDIA years 10, 15, and 20.
At year 10, participants had a mean age of 35.1 years, median eGFRcys of 114mL/min/1.73m(2), and 24.5% had BMI≥30.0kg/m(2). After age 30 years, average eGFRcys was progressively lower with each increment in BMI after adjustment for baseline age, race, sex, hyperlipidemia, smoking status, and physical activity. Higher BMI category was associated with successively higher odds of rapid decline (for 25.0-29.9, 30.0-39.9, and ≥40.0kg/m(2), adjusted ORs were 1.50 [95% CI, 1.21-1.87], 2.01 [95% CI, 1.57-2.87], and 2.57 [95% CI, 1.67-3.94], respectively). 18 participants (0.6%) had incident eGFRcys<60mL/min/1.73m(2). In unadjusted analysis, higher BMI category was associated with incident eGFRcys<60mL/min/1.73m(2) (for 25.0-29.9, 30.0-39.9, and ≥40.0kg/m(2), ORs were 5.17 [95% CI, 1.10-25.38], 7.44 [95% CI, 1.54-35.95], and 5.55 [95% CI, 0.50-61.81], respectively); adjusted associations were no longer significant.
Inability to describe kidney function before differences by BMI category were already evident. Absence of data for measured GFR or GFR estimated from serum creatinine level.
Higher BMI categories are associated with greater declines in kidney function in a cohort of young adults with preserved GFR at baseline. Clinicians should vigilantly monitor overweight and obese patients for evidence of early kidney function decline.
确定潜在的可改变的风险因素对于降低慢性肾脏病的负担至关重要。我们试图在基线肾小球滤过率(eGFR)正常的年轻成年人队列中,研究体重指数(BMI)与肾功能下降的关系。
纵向队列研究。
2839 名黑人和白人年轻人,他们的胱抑素 C 估算肾小球滤过率(eGFRcys)>90mL/min/1.73m2,参加了冠状动脉风险发展在年轻人(CARDIA)研究的第 10 年(1995-1996 年)检查。
BMI,分为 18.5-24.9(参考)、25.0-29.9、30.0-39.9 和≥40.0kg/m2。
10 年随访期间肾功能下降的轨迹、快速下降(>3%/年)和 eGFRcys<60mL/min/1.73m2 的发生率。
使用 CKD-EPI(慢性肾脏病流行病学合作)方程估算的胱抑素 C 的肾小球滤过率(GFRcys),在 CARDIA 年 10、15 和 20 进行校准。
在第 10 年,参与者的平均年龄为 35.1 岁,中位 eGFRcys 为 114mL/min/1.73m2,24.5%的 BMI≥30.0kg/m2。调整基线年龄、种族、性别、高脂血症、吸烟状况和体力活动后,30 岁后平均 eGFRcys 随 BMI 的增加而逐渐降低。较高的 BMI 类别与快速下降的几率呈正相关(对于 25.0-29.9、30.0-39.9 和≥40.0kg/m2,调整后的 OR 分别为 1.50[95%CI,1.21-1.87]、2.01[95%CI,1.57-2.87]和 2.57[95%CI,1.67-3.94])。18 名参与者(0.6%)发生 eGFRcys<60mL/min/1.73m2。在未调整的分析中,较高的 BMI 类别与 eGFRcys<60mL/min/1.73m2 的发生率呈正相关(对于 25.0-29.9、30.0-39.9 和≥40.0kg/m2,OR 分别为 5.17[95%CI,1.10-25.38]、7.44[95%CI,1.54-35.95]和 5.55[95%CI,0.50-61.81]);调整后的关联不再显著。
在 BMI 类别已经存在差异之前,无法描述肾功能。缺乏测量肾小球滤过率或血清肌酐水平估算的肾小球滤过率的数据。
在基线肾小球滤过率正常的年轻成年人队列中,较高的 BMI 类别与肾功能下降的幅度更大有关。临床医生应警惕超重和肥胖患者早期肾功能下降的证据。